Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

114 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Extracorporeal membrane oxygenation as a novel bridging strategy for acute right heart failure in group 1 pulmonary arterial hypertension.
Rosenzweig EB, Brodie D, Abrams DC, Agerstrand CL, Bacchetta M. Rosenzweig EB, et al. ASAIO J. 2014 Jan-Feb;60(1):129-33. doi: 10.1097/MAT.0000000000000021. ASAIO J. 2014. PMID: 24299971
Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects.
Rosenzweig EB, Kerstein D, Barst RJ. Rosenzweig EB, et al. Circulation. 1999 Apr 13;99(14):1858-65. doi: 10.1161/01.cir.99.14.1858. Circulation. 1999. PMID: 10199883 Clinical Trial.
Pulmonary arterial hypertension in children.
Rosenzweig EB, Widlitz AC, Barst RJ. Rosenzweig EB, et al. Pediatr Pulmonol. 2004 Jul;38(1):2-22. doi: 10.1002/ppul.20051. Pediatr Pulmonol. 2004. PMID: 15170869 Review.
Outcomes in children with idiopathic pulmonary arterial hypertension.
Yung D, Widlitz AC, Rosenzweig EB, Kerstein D, Maislin G, Barst RJ. Yung D, et al. Among authors: rosenzweig eb. Circulation. 2004 Aug 10;110(6):660-5. doi: 10.1161/01.CIR.0000138104.83366.E9. Epub 2004 Aug 2. Circulation. 2004. PMID: 15289375
New predictors of outcome in idiopathic pulmonary arterial hypertension.
Kawut SM, Horn EM, Berekashvili KK, Garofano RP, Goldsmith RL, Widlitz AC, Rosenzweig EB, Kerstein D, Barst RJ. Kawut SM, et al. Among authors: rosenzweig eb. Am J Cardiol. 2005 Jan 15;95(2):199-203. doi: 10.1016/j.amjcard.2004.09.006. Am J Cardiol. 2005. PMID: 15642552
Idiopathic pulmonary arterial hypertension in children.
Rosenzweig EB, Barst RJ. Rosenzweig EB, et al. Curr Opin Pediatr. 2005 Jun;17(3):372-80. doi: 10.1097/01.mop.0000163356.51027.c1. Curr Opin Pediatr. 2005. PMID: 15891429 Review.
Effects of long-term bosentan in children with pulmonary arterial hypertension.
Rosenzweig EB, Ivy DD, Widlitz A, Doran A, Claussen LR, Yung D, Abman SH, Morganti A, Nguyen N, Barst RJ. Rosenzweig EB, et al. J Am Coll Cardiol. 2005 Aug 16;46(4):697-704. doi: 10.1016/j.jacc.2005.01.066. J Am Coll Cardiol. 2005. PMID: 16098438
von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension.
Kawut SM, Horn EM, Berekashvili KK, Widlitz AC, Rosenzweig EB, Barst RJ. Kawut SM, et al. Among authors: rosenzweig eb. Chest. 2005 Oct;128(4):2355-62. doi: 10.1378/chest.128.4.2355. Chest. 2005. PMID: 16236894
Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension.
Kawut SM, Horn EM, Berekashvili KK, Lederer DJ, Widlitz AC, Rosenzweig EB, Barst RJ. Kawut SM, et al. Among authors: rosenzweig eb. Pulm Pharmacol Ther. 2006;19(5):370-4. doi: 10.1016/j.pupt.2006.01.001. Epub 2006 Feb 17. Pulm Pharmacol Ther. 2006. PMID: 16483811
Emerging treatments for pulmonary arterial hypertension.
Rosenzweig EB. Rosenzweig EB. Expert Opin Emerg Drugs. 2006 Nov;11(4):609-19. doi: 10.1517/14728214.11.4.609. Expert Opin Emerg Drugs. 2006. PMID: 17064221 Review.
114 results
Jump to page
Feedback